Arzneimittel in der aquatischen Umwelt

The German Environmental Advisory Council evaluated German water protection policies in its last environmental report (2004) concluded that despite some great successes in this area there is still considerable need for action. Specifically, diffuse nutrient and chemical substances inputs remain an unsolved problem. The contamination of surface and groundwater with pharmaceuticals has been identified as an environmental risk increasing in pertinence. Pharmaceuticals and their metabolites are being detected in the whole aquatic environment, which they enter through sewage, soil contamination by agriculture, and waste storage facilities. Different pharmaceuticals have been tested for acute toxicity on various aquatic organisms, but almost nothing is known about chronic toxicity of these contaminants. This knowledge, however, is essential for estimating the ecotoxicological potential of pharmaceutical residues. In the opinion of the Environmental Council different strategies are necessary, to reduce the contamination of the environment with pharmaceuticals. Farmers should refrain from using pharmaceuticals for prophylactic purposes or from using hormonally or antibiotically active substances in livestock feed additives, so as to reduce inputs of veterinary drugs. As regards human medications, packaging should better correspond to appropriate dosage amounts, and environmentally responsible disposal measures should be followed. Still under discussion are a programme for the risk evaluation of existing pharmaceuticals and a ban on the use of sewage sludge in agriculture. In the future, improvement of sewage treatment facilities, for instances through membrane technologies, will offer further potential to reduce inputs of hazardous substances.     

Bewertung der Umweltrelevanz von Arzneistoffen

Aim The aim of this work was to investigate, which human and veterinary pharmaceuticals are of high ecological relevance due to the input into the environment as well as with regard to the effects and behaviour in the environment. Furthermore, the state of knowledge concerning the ecologically relevant substances and the need of research was evaluated. Methods A two-step approach considering the criteria quantity of sold pharmaceuticals, concentrations, effects and fate in the environment was developed to identify the pharmaceuticals of potential ecological relevance. In a second step the identified individual substances and groups of substances were considered in more detail concerning metabolism, environmental behaviour and ecological effects. Results In a first step 29 out of approximate 2,700 licensed human pharmaceuticals and seven substances as well as three substance groups used in veterinary medicine were identified as potentially ecologically relevant. The detailed assessment in a second step lead to the conclusion, that of the human pharmaceuticals 9 substances as well as two substance groups concerning the environmental behaviour and seven substances concerning the effects are of high environmental relevance. Concerning the environmental behaviour six out of seven veterinary pharmaceuticals as well as three substance groups and only three substances concerning the ecological effects were classified as relevant for the environment. Discussion By means of the presented method it was possible to limit the scope of a wide spectrum of pharmaceuticals, so that a detailed assessment of only relevant active agents was possible. Nevertheless, it is a precondition that investigations concerning the occurrence, fate and effects of the individual compounds in the environment have been already carried out and published in the literature. Conclusions The method is suitable for a comprehensive assessment of the ecological relevance of pharmaceuticals, but for a lot of human and veterinary pharmaceuticals the data available in the literature are insufficient. Recommendations For a final extensive assessment of the environmental relevance for some of the human and veterinary pharmaceuticals more studies are necessary. Especially data concerning the environmental behaviour in water and soils, data from long-term-studies for the assessment of ecological effects and data concerning metabolites and mixtures of pharmaceutical compounds are lacking.     

Pharmaceutical compounds in aquatic environment in China: locally screening and environmental risk assessment

An environmental risk assessment was performed for pharmaceutical compounds present in the aquatic environment of China. Predicted environmental concentration (PEC) of the compounds were calculated according to European Medicines Evaluation Agency (EMEA) guidelines. Available ecotoxicological data compromised by applying a very conservative assessment factor (AF) were employed to calculate the predicted no-effect concentration (PNEC). The screening principle and the risk assessment were based on risk quotient (RQ), which derived from the PEC and related PNEC values. PEC results indicated that all the compounds except sulfadimethoxine and levocarnitine, should carry out phase II risk assessment in EMEA guideline. RQ values suggested that more than 36 pharmaceuticals may be imposed health threats to the aquatic environment; especially the antibiotic therapeutic class including amoxicillin, sulfasalazine, trimethoprim, oxytetracycline and erythromycin showed high RQ values. These substances with high RQ value (RQ≥1) were regarded as top-priority pharmaceuticals for control in the aquatic environment of China. However, the antibiotic substances which had low risk quotient (RQ <1), should be reassessed by its potentially induced resistance under low concentration in future.     

基于自然环境中优选药物的毒性和生态毒理风险研究

在如今超过1 500种在用原料药中,环境中发现几率明确和对环境影响明确的原料药所占比例很小。由于很难监管所有在用原料药,众多先前的研究提议将原料药按照受关注程度排序,从而可以将研究资源集中于那些最受瞩目的药物。然而这些研究都存在局限性,本文从之前优先性方法的实践经验出发,提出了一种更为全面的原料药排序方法。该方法基于对水生生物、土壤生物、鸟类、野生哺乳动物和人类的风险,综合考虑了食物链顶端存在的生态毒理学研究终点和由这些治疗性药物作用机制带来的非顶端效果。对于在英国社区以及医院设置中使用的146种活性药物的分析可以更为详细地说明该方法的运用。根据这一方法,我们将16种化合物列为优先考虑的药物。这些药物包括了抗生素、抗抑郁药、抗炎药、抗糖尿病药、抗肥胖药、雌激素类化合物以及相关的代谢产物。我们建议这种优先性方法在将来可以更广泛地应用于世界上不同的地区。
精选自Jiahua Guo, Chris J. Sinclair, Katherine Selby, Alistair B.A. Boxall. Toxicological and ecotoxicological risk based prioritisation of pharmaceuticals in the natural environment. Environmental Toxicology and Chemistry: Volume 35, Issue 7, pages 1550–1559, July 2016. DOI: 10.1002/etc.3319
详情请见http://onlinelibrary.wiley.com/doi/10.1002/etc.3319/full
     

Processes of distribution of pharmaceuticals in surface freshwaters: implications for risk assessment

The global consumption and production of pharmaceuticals is increasing concomitantly with concern regarding their environmental fate and effects. Active pharmaceutical ingredients are mainly released into the aquatic environment through wastewater effluent discharge. Once in the environment, pharmaceuticals can undergo processes of natural attenuation, i.e. dilution, sorption, transformation, depending on physico-chemical properties of the compound, such as water solubility, lipophilicity, vapour pressure, and environmental conditions, such as pH, temperature and ionic strength. A major natural attenuation process is the sorption on dissolved organic matter, colloids, suspended solids and sediments, which in turn control pharmaceuticals distribution, residence time and persistence in aquatic systems. Here we review studies of sorption capacity of natural sorbents to pharmaceuticals. These report on the importance of several environmental and sorbent-specific properties, such as the composition, quality, and amount of the sorbent, and the environmental pH, which determines the speciation of both the sorbent and compound. The importance of accounting for distribution processes on freshwater sorbents for any determination of environmental concentrations of pharmaceuticals is apparent, while the reliability of surrogate standards for measuring dissolved organic matter (DOM) distribution is evaluated in the context of the need for robust environmental risk assessment protocols.     

防污漆中活性物质海洋环境风险评估关键技术探讨

防污漆中的活性物质对海洋生态环境和人类健康造成的潜在风险受到日益广泛的关注,一些发达国家已建立了针对活性物质海洋环境风险评估的技术体系,但我国相关研究目前尚属空白。综述了防污漆活性物质海洋环境风险评估的研究背景、相关法规、技术标准和发展现状,针对环境风险评估的2个重要组成部分(危害性评估和暴露评估)中的关键技术进行了探讨。在危害性评估中,重点分析和比较了受试生物物种的选择原则、生态毒理数据的要求以及预测无效应浓度的推导方法和应用范围;在暴露评估中,系统阐述了活性物质在水环境中释放速率的计算及修正方法、环境浓度的预测模型、现有的暴露场景及其局限性等。本文以期为我国开展防污漆活性物质海洋环境风险评估提供研究基础和科学依据,并提出了今后的研究重点和方向。     

Priorisierung von bioziden Wirkstoffen aufgrund der potenziellen Gefährdung schweizerischer Oberflächengewässer

Background, Aim and Scope Active substances for use in biocidal products can potentially occur as micropollutants in natural waters. Biocides, which are used in Switzerland for non-agricultural applications, should be evaluated and prioritized with regard to their respective environmental risks. The following questions were emphasized: Which active substances are used for which purposes and in which amounts? Is there discharge to the aquatic environment? What are the environmental behaviours and ecotoxicological effects of these biocides? How can a prioritization be achieved? Which active substances should be suggested for further assessments? Methods Manufacturing firms, sales organisations, users and environmental experts were identified as key stakeholders for the issues of this project. Chemical identities, product compositions, used amounts, product types, ways and places of applications were elucidated. A database was established with information on approximately 1760 products with totally 277 active substances. A prioritization procedure was established, providing a distinction of the active substances. For priority setting, water pollution risks by biocides were evaluated based on potential environmental emissions as well as on environmental behaviour and ecotoxic effects. Results In the European Union 372 active substances were notified for biocidal products, which accounted for use of 7500 tons per year in Switzerland. More than 95?% of the total use bases on 30 active substances, of which seven are rapidly biodegradable. A group of experts determined 22 substances as candidates for an extended assessment. It became evident that many active biocidal substances are highly ecotoxic und could, therefore, cause an augmented environmental risk Discussion It could be shown which active substances are applied in Switzerland in substantial amounts. Although close to 300 active biocidal substances are used, only about 30 substances are employed in relevant amounts of more than 5000?kg per year. For 22 active substances with low biodegradability, a potential environmental risk for natural surface waters can be inferred. These active substances are used at amounts comparable to the pesticides.     

Erfahrungen des Umweltbundesamtes mit der EU-Biozid-Richtlinie

Biocides are active substances and products which are intended to destroy (…) any harmful organism by chemical or biological means. Typical applications are for instance wood preservatives, antifouling products or disinfectants. In the European Union the use of biocidal products is regulated since 1998 by the Biocidal Product Directive 98/8/EG (BPD). The BPD was transposed into German law in 2001 by the “Biozid-Gesetz”. The Federal Environment Agency is responsible for the environmental risk assessment of biocidal active substances and products under the “Biozid-Gesetz” in Germany. The European Commission has to evaluate the BPD seven years after endorsement and if necessary, has to submit a proposal for the revision of the directive. It is expected that the European Commission will publish soon a review of the enforcement of the BPD together with suggestions for the revision of the directive. In this article the German Federal Environment Agency summarises suggestions for the revision of the BPD based on its ten years experience with the directive: The scope of the BPD needs an exact clarification of borderlines in order to avoid confusion with other legislation. Food and feeding stuff together with natural products like lavender branches and cedar wood, which are used as attracting or repellent agents, have to be excluded from the scope of the BPD. Special data requirements for natural oils and pheromones should be developed to take the complex composition of these substances into account. The advantages of a centralised and decentralised authorisation procedure are discussed for biocidal products in special product types. Furthermore we stipulate that biocidal active substances which are nano particles are treated as separate active substances with own identities. Due to animal welfare reasons it should be obligatory to share data from vertebrate animal studies as it is already mandatory under the REACH regulation. The import of articles treated with biocidal active substances into the European market should only be allowed, if the active substance is approved for their biocidal use within the EU. Finally we suggest to implement an obligation to report the market shares or consumption rates of biocidal active substances and products. Together with procedural simplifications and adaptation in the scope of the directive, changes of the data requirements will be the key issues during the revision of the BPD. Most important, these changes should not reduce but ideally increase the level of protection for human health and the environment.     

环境内分泌干扰物低剂量-效应研究进展

环境内分泌干扰物(EDCs)的低剂量-效应已成为生态毒理学界的研究热点.环境内分泌干扰物在接近或低于无可见不良效应浓度水平(NOAEL)时仍可诱发生物效应并存在非单调剂量-效应关系,这对现行的动物繁殖和发育毒理学检测规程以及环境内分泌干扰物风险评价的理论和方法提出了挑战.此外,由于环境中内分泌干扰物呈低剂量长期暴露的特征,研究低剂量-效应对正确进行生态风险评价具有重大的科学意义.在总结国内外相关研究的基础上,对当前环境内分泌干扰物低剂量-效应的研究进展进行了综述.     

Humanpharmakawirkstoffe in der Umwelt: Einträge, Vorkommen und der Versuch einer Bestandsaufnahme

Background

The presence of a large spectrum of pharmaceutical agents has been reported for aquatic environments (surface—and groundwater) and other aquatic media (influents and effluents of sewage treatment plants) in Germany and beyond, including their occurrence in drinking water. Considering the large number of pharmaceuticals produced for human use and released into the environment, various authors (Sattelberger 1999, Hanisch et al. 2004, Castiglioni et al. 2006, IWW 2006, Stockholm County Council 2006) tried to compile ‘priority lists’ focusing on those substances with environmental relevance. The following agents are included in all lists: ciprofloxacine, clarythromycine (antibiotics), carbamazepine (anti-epileptic agent), bezafibrate (lipid reducer), clofibric acid (lipid reducer metabolite), ethinylestradiol (sex hormone) and cylophosfamide (cytostatic agent). The agents erythromycine and sulfamethoxazole (antibiotics), ibuprofen, indometacine, propyphenazone (analgesics), atenolol (beta-blocker) and ifosfamide (cytostatic agent) can be found in three of four priority lists.

Results

Pharmaceuticals mainly enter the aquatic environment via effluent water, coming from wastewater treatment plants (including hospital and household sewerage), untreated discharges (e.g, secondary transfer of active agents into ground- and surface waters via sewage sludge application in agriculture and via landfill leachate) and leakages in the municipal sewer network.

Discussion

Potential activities towards a reduced release of pharmaceuticals into the environment should consider primarily the origin of the exposure to allow a separation of drug containing flows already at the source. Following the latter it would be possible to minimize the contamination of spring-, ground- and surface waters which serve as raw water resources for drinking water supply. However, considering the actual water pollution with pharmaceuticals and other substances, ‘end-of pipe’ techniques in the sewage and drinking water treatment are absolutely essential.

Conclusions

Sustainability criteria (e.g. protection of drinking water resources, habitats and biocoenoses, recycling and economizing use of resources) and economic aspects of modern sewage disposal concepts require a useful choice and combination of technical measures as components of centralized and decentralized sewage and drinking water treatment methods. It is though not realistic to cover and eliminate all pharmaceutical agents of environmental relevance equally effective even if a catalogue of potential technical treatment methods is elaborated thoroughly. Therefore, a concentration of efforts on selected drug agents, at least following initially some of the priority lists, is recommended.

Recommendations and Perspectives

The contamination of the water cycle with pharmaceuticals is nevertheless not exclusively to be solved via the application of technical methods. The BMBF (Federal Ministry for Education and Research) funded project start (Management Strategies for Pharmaceuticals in Drinking Water, www.start-project.de) therefore tries by implementation of a transdisciplinary approach to integrate technical-, behavioral-, and agent-orientated management strategies towards a more comprehensive and sustainable problem solution.     

Expositionsszenarien nach REACH

Object and Background

Production and use of substances and formulations can result in exposures on humans and the environment. In October 2003, the European Commissions presented a proposal for the registration, evaluation, assessment and restriction of chemicals (REACH). Assessment of exposures will become an essential element of REACH for certain substances. For many manufacturers and users of substances and formulations these tasks are new. Pilot projects to REACH have shown so far that solutions and instruments for these tasks which meet the requirements of real life situations have yet to be developed.

Discussion and Conclusions

Within the REACH proposal, exposure scenarios are a main element of the chemical safety assessment. This article outlines the contents of exposure scenarios. It reflects experiences with exposure scenarios and discusses possibilities of standardization. It covers exposure steps/categories and possibilities to build product groups. Non-branch specific types of exposure situations are an important element of exposure scenarios. Therefore, exposure steps/categories should be contained in exposure scenarios. Nevertheless, these elements structure only a specific part of the information contained in exposure scenarios. Hence they cannot replace exposure scenarios. Exposure categories do not reveal the uses, the processes and the activities connected with the intended use of substances. These information are important parts of a complete exposure scenario. They are the basis for the following step of risk characterisation. In addition, they provide the necessary transparency regarding the use patteern of substances.     

Arzneimittelentwicklung: Die Reduzierung von Umweltbelastungen durch gezieltes Moleküldesign

Results of the study In a long-term perspective innovations which are directed towards the principles of sustainable active pharmaceutical ingredients (APIs) will result in substituting problematic substances with other ones which are therapeutically effective as well as degradable in an environmentally compatible way. The substitution leads to a considerable decrease in water pollution with respect to the influx of APIs. The article summarizes the standard of knowledge considering measures with which such innovations and the consequent water improvement can be achieved. Discussion With an adequate promotion of research within this field and a modified scientific education the appliance of specific molecular designs could be established in the pharmaceutical sciences and industry. Examples will show that this, as a first step, may result in effective structures (model structures, which are already comprising synthetic substances) being modified so as to achieve a good degradability. By providing a list with evaluated and successfully established practical examples the basic practicability of this approach can convincingly be demonstrated. Especially within a changed political framework it will on this basis be possible as a second step to show that the approach also works in a systematic way when it comes to a broader development of new substances. With the help of advertising efforts the swift establishment of those innovations within the pharmaceutical market can be achieved thus supporting an accelerated environmental relief. Conclusions There is an option to develop a method of resolution, which will bring forward a trans-formation within the pharmaceutical industry with respect to a sustainable development. Those new methods furthering an improved degradability of pharmaceutical substances will result in an important reduction of influx into the environment and they will at the same time be able to improve the pharmaceutically relevant properties. Recommendations and perspectives The hereby suggested strategic approach is also applicable for environmentally relevant chemicals, i.?e. not for pharmaceuticals only.     

Preliminary survey of pharmaceutical residues in some important Romanian rivers

A number of important rivers of Romania were investigated for pharmaceutical and antifungal residues. In a post target approach analysis, a single-stage, high-resolution mass spectrometry was successfully applied for the screening of 43 pharmaceuticals and fungicides in water, using U-HPLC-Exactive Orbitrap MS at 50,000 full width at half maximum resolution. Detection was based on accurate masses and retention times. The study confirmed the presence of pharmaceuticals and antifungals such as diclofenac, sulfamethoxazole, carbamazepine, trimethoprim, thiabendazole, and clotrimazole, in water. Diclofenac and carbamazepine were the most frequently detected (eight samples); concentrations ranged from 5 to 50 ng L^?1. Low concentrations of griseofulvin were detected in the Prut River. Further monitoring studies should be carried out in order to fill the gaps of knowledge concerning the presence of pharmaceutical residues in Romanian water environment and to improve public understanding regarding the environmental risk of pharmaceutical contamination.     

Interested consumers’ awareness of harmful chemicals in everyday products

Background

Everyday products can contain a multitude of harmful substances unnoticed by most consumers, because established risk communication channels reach only part of the society. The question is, whether at least interested and informed consumers are able to use risk communication tools and assess harmful chemicals in products.

Results

An online survey investigated the awareness of 1030 consumers on harmful substances in everyday items. Participating consumers’ education level, knowledge in chemistry, and motivation were above society’s average. Although a large number of responses showed that survey participants were familiar with several aspects of the issue, the results revealed that knowledge in chemistry helped, but was not enough. Many participants assumed that products with an eco-label, natural personal care products, products without hazard pictograms or products produced in the European Union would not contain harmful substances. Most participants indicated to use hazard pictograms, information on the packaging, reports in the media, and environmental and consumer organizations as information sources, while information by authorities and manufacturers were not named frequently and did not receive high confidence. Smartphone applications were not indicated by many participants as information sources. The information sources most trusted were environmental and consumer organizations, hazard pictograms, and lists of ingredients on the containers. The declared confidence in certain risk communication instruments did not always correspond to the use frequencies indicated. Nearly all participants considered legislators as responsible for the reduction of harmful substances in consumer products.

Conclusions

Misconceptions about harmful substances in products can be dangerous for the personal health and the environment. The survey indicates that motivation, educational level, and chemical expertise do not automatically provide an appropriate understanding of harmful substances in products. If well-informed consumers are not sufficiently capable to use risk information elements as revealed in this study, then this will be even more the case for the general public. Consumer awareness should be stipulated by an improved information strategy about chemical risks in consumer products with an extensive participation of the target groups and by more efforts by authorities and manufactures to build trust and to provide easily understandable information.

     

Wassertechnische Strategien zur Reduzierung der Trinkwasserbelastung durch Arzneimittelwirkstoffe

Results The available research results concerning the application of innovative methods of wastewater and drinking water purification to eliminate pharmaceuticals are summarized in the present paper. An increase of the activated sludge (aerobic sludge) age to 8–10 days in treatment plants can improve the metabolization of less persistent pharmaceutical agents whereas expansion of the sojourn time beyond 10 days will not result in a remarked increase of degradation for most pharmaceutical substances. First results have shown that wastewater treatment plants with integrated membrane bioreactors (MBR) using micro- and ultrafiltration membranes do not provide significantly better results compared to the conventional wastewater treatment plants with respect to the removal of organic micropollutants (including pharmaceutical residues). The use of powdered carbon in biologically treated wastewater is able to reduce pharmaceutical residues up to 80?% in the run-off water. Pilot studies scrutinize the treatment of highly contaminated effluents via catalytic photooxidation. Regarding the suitability of the method to reduce the contamination of drinking and wastewater with pharmaceuticals yet only few data from laboratory scale testing are available. Activated carbon filtration is preferably used for drinking water treatment. Primarily against the background of disinfection, ozonation is widely used for drinking water treatment, but for wastewater treatment the method is still at the experimental stage and will hardly become of practical importance because of high costs. Sustainable wastewater separation is grounded on decentralized concepts by considering material cycles (recycling) at the place of origin. In the long term, separation measures can significantly contribute to declining drug concentrations in drinking water. Regarding the quarrying of drinking water by bank filtration water, river water or artificially enriched ground water, end-of-pipe techniques are vital. Most commonly, activated carbon or activated carbon combined with ozonization is applied and assures a high drinking water quality. Discussion The advantages and disadvantages of the different water treatment methods mainly concern the varying degrees of effectiveness with respect to the elimination of very persistent pharmaceutical agents, the generation of problematical metabolites and additional waste materials, hygienic problems, energy needs and the necessity to employ appropriate technical staff for operation. Although the biodegradation of very persistent drugs cannot be enhanced by an extension of the activated sludge age, this modification should be considered in sewage plants to reduce the contamination with less persistent medical agents. Compared with conventional wastewater treatment, membrane bioreactors provide the advantage of a better control of biological activities on the plant and a comparably small plant size but high investment and operation costs. Additionally, pharmaceuticals such as carbamazepin are only insufficiently removed from wastewater by membrane bioreactors. The regular use of powdered activated carbon in sewage treatment plants would also increase the costs of wastewater treatment and would additionally exclude the further use of sewage sludge in agriculture. Currently, in Germany the further use of sewage sludge is handled differently by the Federal States and discussed controversially. The implementation of ozonation as an additional treatment method in wastewater treatment plants is not realistic because of cost concerns. Additionally, the method produces analytically as yet not assessed metabolites with unknown (eco-)toxicological impacts. For this reason ozonation should currently not be applied unless the reaction products are removed subsequently by filtration through activated carbon. For industrial sewage photooxidation is in a state of testing but an application for municipal wastewater is, up to now, out of question. When river bank filtration is used for the supply of drinking water the use of activated carbon for purification should be essential. The lifetime of the filters is often defined by the filter capacities to eliminate radiocontrast media (e.?g., iopamidole, amidotrizoic acid). Many water supply companies already apply the ozonization prior to activated carbon filtration which supports the elimination of pharmaceuticals from the sewage. The unique developmental potential of the wastewater separation can be seen in the possibility to link up these methods with sustainable exploitation techniques and concepts (re-use of sanitized water, production of fertilizer, compost and biogas). Wastewater separation will not make ‘middle/end-of-pipe’ techniques dispensable but will make their handling more effective because concentrations of pharmaceutical agents are higher in separated effluents compared to those usually found in municipal wastewater, which in mixing sewage systems is even diluted by surface runoff. Conclusions Following today’s state of knowledge activated carbon filtration (eventually coupled with ozonization) is best suited to remove drug residues and other xenobiotics from raw water. Water works that do not apply the activated carbon filtration technique for cleanup of bank filtration water should consider an upgrade. The ozonization is primarily required for disinfection of the water. As no acute health hazard proceeds from drinking water contamination by pharmaceuticals at the present time, the upgrade of wastewater treatment plants by one of the aforementioned innovative methods is currently not required in view of drinking water quality. This offers the opportunity to develop sustainable approaches that already aim to reduce drug contaminations of wastewater and hence of ground-, surface- and drinking water. Recommendations and perspectives On a short- to mid-term perspective enriched sewage of hospitals, nursing homes and other medical facilities should be collected and treated separately. From a technical point of view the conditioning of separated hospital effluents (yellow- and greywater) via activated carbon or membrane filtration is possible but should be combined with disinfection. On a mid- and long-term scale sustainable sanitary concepts based on wastewater separation (black-, grey- and/or rainwater) associated with the recycling of mineral nutrients (nitrogen, phosphorous and potassium) should be realized for development, industry and trade areas, buildings with public lavatories, airports, motorway service areas, and large office and hotel buildings. Strategies focusing primarily on up-grading of municipal wastewater treatment plants are currently existing but the related technologies are largely in a test phase. This is why a particular technique should not be favored at the moment. The combination of various techniques (i.?e., ozonization combined with activated carbon filtration) is known to be very efficient for the removal of pharmaceutical residues from water, but the combination cannot be expected to become of importance in treatment of domestic wastewater because of high costs. Moreover, improvement of wastewater treatment technologies to remove pharmaceutical residues will not make the employment of end-of-pipe techniques in water works redundant and therefore will not lead to saving of expenses.     

Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.

Eight pharmaceuticals were selected on the basis of their domestic consumption in Japan, the excretion ratio of the parent compound and the frequency of detection in the aquatic environment or wastewater treatment plant effluent. Toxicity tests on these pharmaceuticals were conducted using Japanese medaka (Oryzias latipes), daphnia (Daphnia magna), and green algae (Psuedokirchneriella subcapitata). Predicted no effect concentration (PNEC) was calculated using lethal or effect concentration 50 (LC50 or EC50) values and no effect concentration (NOEC) obtained in the toxicity tests for these compounds. Predicted environmental concentration (PEC) was also calculated from annual consumption, the excretion rate of the parent compound, and removal rate in the preliminary batch activated sludge treatment performed in this study. Maximum concentrations found in the aquatic environment or sewage effluent in Japan or foreign countries were also used for another calculation of PEC. Initial risk assessment on the selected pharmaceuticals was performed using the PEC/PNEC ratio. The results of initial risk assessment on the eight selected pharmaceuticals suggest neither urgent nor severe concern for the ecological risk of these compounds, but further study needs to be conducted using chronic toxicity tests, including reproduction inhibition and endocrine disruption assessments.     

Pharmaceuticals,endocrine disruptors,personal care products,nanomaterials and perfluorinated pollutants: a review

The presence of emerging micropollutants such as pharmaceuticals, endocrine disruptors, personal care products, nanomaterials and perfluorinated substances in the environment remains a great threat to the health and safety of humans and aquatic species. These micropollutants enter the environment via anthropogenic activities and have been detected in surface water, groundwater and even drinking water at nanogram per litre to microgram per litre concentration. To date, limited information exists on the fate, behaviours, and pathways of these micropollutants in the environment. The potential ecotoxicological effects on the receptors due to exposure to individual or mixture of these chemicals still remain unknown. This review provides an overview on pharmaceuticals, endocrine disrupting compounds, personal care products, nanomaterials and perfluorinated pollutants, with emphasis on their occurrences, effects, environmental fates, and potential risk of exposure in water, soil or sediment. Based on the literature survey, it was found that in spite of an extensive research and different developmental efforts on the challenges of emerging micropollutants, the solution to the problem of emerging micropollutants in the environment is far from being solved. The needs for behavioural change among citizens, strong political will and policy formulation on the part of government are identified as possible panacea for combating the growing influence of these potential damaging substances. Suggestions on proactive and precautionary measures that must be taken to protect the environment as well as guarantee the health and safety of humans and aquatic species are provided. Future research should concentrate on the development of a risk based screening models and framework that can predict the sources, fate and behaviours of emerging contaminants in the environment is recommended.     

湿地生态风险评价中生物完整性指数研究进展

湿地是陆地与水域之间的过渡地带,是地球上生产力最高的生态系统。湿地生态风险评价的实际应用将使人们更好地理解物理、化学和生物风险源如何影响湿地,并为湿地管理提供科学支撑,这就要求确定湿地生态健康评价指标的完整性。生物完整性指数以环境生态毒理学数据为依据,是进行生态系统健康风险评价的最有力工具。大中型无脊椎动物作为易选择的分类群,可用于湿地评估的生物完整性指数的建立,土壤动物特别是线虫类群作为湿地土壤和水环境健康评价的指示生物具有广阔前景。通过线虫分子毒理学等研究方法,可优化出生物完整性指数体系,建立扰动背景下的湿地生态风险评价模型,为湿地污染的监测、防控和修复,提供理论依据和实践方法。